$65.49

+3.55 (+5.73%)

Weekly Expected Move ±6.8%

$49 $52 $56 $60 $64

NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 64 · $3.0B mcap · 45M float · 1.75% daily turnover · Short 65% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE

63.5 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 10.3% · 5Y Avg: 9.1%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. HAE has a Narrow competitive edge (63.5/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 10.3% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$67

Low

$78

Avg Target

$89

High

Based on 2 analysts since May 7, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 10Hold: 10Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$75.33

Analysts3

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-12	Barrington	—	$94	$89	-5	+70.4%	$52.24
2026-05-08	Robert W. Baird	David Rescott	$81	$67	-14	+30.0%	$51.55
2026-04-13	Mizuho Securities	Anthony Petrone	$80	$70	-10	+22.0%	$57.39
2026-02-06	Robert W. Baird	—	$99	$81	-18	+31.9%	$61.40
2026-02-06	Barrington	—	$93	$94	+1	+44.6%	$65.02
2026-02-06	Mizuho Securities	—	$90	$80	-10	+23.0%	$65.02
2026-01-12	Barrington	—	Initiated	$93	—	+13.4%	$82.03
2025-12-17	Mizuho Securities	—	Initiated	$90	—	+11.0%	$81.11
2025-12-15	Robert W. Baird	—	Initiated	$99	—	+23.2%	$80.33
2025-11-14	Raymond James	Andrew Cooper	$120	$90	-30	+21.8%	$73.91
2025-11-06	BTIG	—	Initiated	$88	—	+32.9%	$66.20
2025-08-07	Needham	Mike Matson	$112	$68	-44	+22.2%	$55.64
2024-11-08	Raymond James	Andrew Cooper	Initiated	$120	—	+60.4%	$74.83
2024-09-13	C.L. King	Kristen Stewart	Initiated	$116	—	+58.3%	$73.26
2024-09-11	Bank of America Securities	Craig Bijou	Initiated	$85	—	+18.7%	$71.61
2024-06-12	Needham	Mike Matson	Initiated	$112	—	+34.3%	$83.41

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. HAE receives an overall rating of B+. Strongest factors: DCF (5/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5), P/B (2/5).

Rating Change History

Date	From	To
2026-05-07	A-	B+
2026-04-01	B+	A-
2026-02-05	A-	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 64 Grade A

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. HAE scores highest in Momentum (84/100) and lowest in Safety (50/100). An overall grade of A places HAE among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.10

Grey Zone

Piotroski F-Score

7/9

✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓ ✗

Beneish M-Score

-2.68

Unlikely Manipulator

Ohlson O-Score

-6.84

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BBB+

Score: 61.7/100

Trend: Deteriorating

Earnings Quality

75/100

OCF/NI: 1.72x

Accruals: -5.2%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. HAE scores 2.10, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. HAE scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. HAE's score of -2.68 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. HAE's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. HAE receives an estimated rating of BBB+ (score: 61.7/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). HAE's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

31.11x

PEG

-0.80x

P/S

2.23x

P/B

3.80x

P/FCF

8.97x

P/OCF

7.94x

EV/EBITDA

8.83x

EV/Revenue

2.42x

EV/EBIT

12.87x

EV/FCF

12.55x

Earnings Yield

7.33%

FCF Yield

11.15%

Shareholder Yield

9.80%

Graham Number

$36.98

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 31.1x earnings, HAE commands a growth premium. An earnings yield of 7.3% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $36.98 per share, 77% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.775

NI / EBT

Interest Burden

0.869

EBT / EBIT

EBIT Margin

0.188

EBIT / Rev

Asset Turnover

0.572

Rev / Assets

Equity Multiplier

2.609

Assets / Equity

ROE

18.9%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. HAE's ROE of 18.9% is driven by Asset Turnover (0.572), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

28.35%

Fair P/E

65.20x

Intrinsic Value

$230.06

Price/Value

0.21x

Margin of Safety

79.06%

Premium

-79.06%

Assessment

Undervalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with HAE's realized 28.3% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $230.06, HAE appears undervalued with a 79% margin of safety. The adjusted fair P/E of 65.2x compares to the current market P/E of 31.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$65.47

Median 1Y

$57.17

5th Pctile

$26.42

95th Pctile

$124.09

Ann. Volatility

44.5%

Analyst Target

$75.33

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Christopher A. Simon President and Chief Executive Officer	$1,100,000	$7,026,668	$10,722,488
James C. D'Arecca Executive Vice President, Chief Financial Officer	$575,582	$1,563,677	$2,975,669
Michelle L. Basil Executive Vice President, General Counsel	$537,870	$1,471,617	$2,794,443
Roy Galvin President, Vice President, Chief Commercial Officer	$490,154	$1,011,733	$2,196,340
Stewart W. Strong Former President, Global Hospital	$476,702	$1,011,733	$1,934,703

CEO Pay Ratio

Insufficient data for pay ratio.

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

—

Revenue / Employee

—

Rev: $1,360,824,000

Profit / Employee

—

NI: $167,679,000

SGA / Employee

—

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	17.2%	12.1%	9.8%	4.7%	3.4%	5.9%	9.1%	11.6%	12.9%	14.7%	17.4%	16.4%	16.2%	13.2%	12.9%	13.9%	14.6%	18.8%	18.3%	18.9%	18.89%
ROA	8.5%	5.1%	4.2%	2.0%	1.5%	2.4%	3.7%	4.7%	5.2%	6.1%	7.2%	6.8%	6.7%	5.7%	5.6%	6.0%	6.3%	7.2%	7.0%	7.2%	7.24%
ROIC	13.0%	4.9%	4.1%	1.8%	1.3%	4.3%	6.4%	7.9%	8.5%	9.8%	11.2%	10.4%	10.3%	8.0%	7.4%	8.2%	9.0%	9.2%	9.6%	10.3%	10.32%
ROCE	12.4%	7.1%	6.0%	5.9%	5.7%	6.3%	8.8%	10.4%	10.9%	9.9%	11.3%	11.0%	12.0%	10.8%	10.7%	11.6%	11.9%	12.2%	12.9%	13.3%	13.34%
Gross Margin	50.0%	49.4%	48.3%	51.2%	53.3%	58.2%	54.3%	53.1%	52.0%	54.0%	53.8%	53.6%	55.0%	55.0%	53.3%	55.3%	57.4%	55.0%	59.7%	56.0%	56.04%
Operating Margin	16.8%	-9.4%	0.6%	10.2%	13.7%	7.2%	11.8%	15.7%	14.2%	11.6%	17.2%	11.1%	13.7%	8.7%	11.8%	15.0%	16.9%	15.6%	16.8%	20.6%	20.55%
Net Margin	13.3%	-4.9%	-1.9%	6.2%	8.9%	3.7%	7.6%	11.2%	10.8%	9.7%	13.2%	7.8%	9.3%	5.9%	11.4%	9.8%	10.8%	17.5%	10.6%	11.8%	11.82%
EBITDA Margin	25.0%	24.3%	7.3%	21.8%	23.1%	21.1%	20.2%	23.8%	21.9%	20.2%	24.6%	20.7%	24.5%	19.9%	23.8%	25.8%	27.3%	24.1%	29.2%	29.2%	29.19%
FCF Margin	13.3%	8.2%	5.8%	5.8%	3.4%	7.6%	8.6%	10.7%	11.3%	13.9%	14.4%	16.1%	10.7%	9.4%	6.0%	3.3%	7.0%	10.5%	14.1%	19.3%	19.29%
OCF Margin	17.4%	12.5%	10.6%	11.7%	11.1%	17.3%	21.0%	23.9%	23.2%	23.4%	20.5%	21.2%	15.5%	13.9%	10.1%	6.2%	9.4%	13.4%	16.8%	21.8%	21.77%
ROE 3Y Avg	snapshot only																				16.36%
ROE 5Y Avg	snapshot only																				12.96%
ROA 3Y Avg	snapshot only																				6.38%
ROIC 3Y Avg	snapshot only																				9.10%
ROIC Economic	snapshot only																				8.89%
Cash ROA	snapshot only																				11.79%
Cash ROIC	snapshot only																				16.62%
CROIC	snapshot only																				14.73%
NOPAT Margin	snapshot only																				13.51%
Pretax Margin	snapshot only																				16.35%
R&D / Revenue	snapshot only																				4.71%
SGA / Revenue	snapshot only																				16.28%
SBC / Revenue	snapshot only																				1.80%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	56.41	71.03	52.61	118.59	120.54	74.85	51.39	44.36	42.07	36.73	32.01	35.89	34.75	37.32	37.13	33.03	30.20	18.75	21.85	13.65	31.110
P/S Ratio	6.90	6.48	3.76	3.97	2.86	3.27	3.39	3.52	3.57	3.63	3.59	3.72	3.46	3.35	3.20	3.00	2.86	2.31	2.65	1.73	2.231
P/B Ratio	10.39	7.71	4.64	5.06	3.72	4.33	4.64	5.09	5.38	5.18	5.34	5.63	5.38	4.57	4.44	4.26	4.09	3.83	4.35	2.80	3.801
P/FCF	51.86	78.65	65.18	68.76	83.19	42.86	39.59	32.82	31.44	26.02	24.87	23.12	32.25	35.64	52.92	89.82	40.95	22.07	18.86	8.97	8.966
P/OCF	39.69	51.88	35.59	33.80	25.75	18.85	16.11	14.71	15.41	15.52	17.47	17.56	22.30	24.14	31.54	48.14	30.39	17.30	15.75	7.94	7.943
EV/EBITDA	29.86	31.75	21.88	23.37	18.03	20.40	18.11	18.12	18.47	18.71	17.59	18.78	17.04	17.11	16.49	14.74	13.70	11.81	12.55	8.83	8.829
EV/Revenue	7.24	7.16	4.40	4.60	3.47	3.79	3.90	4.00	4.03	4.04	3.98	4.10	3.84	3.83	3.67	3.47	3.32	2.99	3.33	2.42	2.420
EV/EBIT	52.18	55.65	42.15	46.45	37.29	41.98	31.94	29.48	29.37	28.20	25.50	27.36	24.22	24.51	24.23	21.53	20.14	17.79	18.52	12.87	12.867
EV/FCF	54.45	86.82	76.44	79.64	101.10	49.74	45.52	37.30	35.51	28.98	27.61	25.54	35.78	40.75	60.73	103.64	47.50	28.52	23.72	12.55	12.551
Earnings Yield	1.8%	1.4%	1.9%	0.8%	0.8%	1.3%	1.9%	2.3%	2.4%	2.7%	3.1%	2.8%	2.9%	2.7%	2.7%	3.0%	3.3%	5.3%	4.6%	7.3%	7.33%
FCF Yield	1.9%	1.3%	1.5%	1.5%	1.2%	2.3%	2.5%	3.0%	3.2%	3.8%	4.0%	4.3%	3.1%	2.8%	1.9%	1.1%	2.4%	4.5%	5.3%	11.2%	11.15%
EV/OCF	snapshot only																				11.120
EV/Gross Profit	snapshot only																				4.245
Acquirers Multiple	snapshot only																				13.875
Shareholder Yield	snapshot only																				9.80%
Graham Number	snapshot only																				$36.98

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	2.20	2.74	2.74	2.74	2.74	1.71	1.71	1.71	1.71	3.06	3.06	3.06	3.06	2.56	2.56	2.56	2.56	1.62	1.62	1.62	1.617
Quick Ratio	1.21	1.46	1.46	1.46	1.46	1.05	1.05	1.05	1.05	2.03	2.03	2.03	2.03	1.50	1.50	1.50	1.50	0.99	0.99	0.99	0.986
Debt/Equity	0.75	1.06	1.06	1.06	1.06	1.04	1.04	1.04	1.04	0.94	0.94	0.94	0.94	0.84	0.84	0.84	0.84	1.49	1.49	1.49	1.492
Net Debt/Equity	0.52	0.80	0.80	0.80	0.80	0.70	0.70	0.70	0.70	0.59	0.59	0.59	0.59	0.66	0.66	0.66	0.66	1.12	1.12	1.12	1.118
Debt/Assets	0.35	0.43	0.43	0.43	0.43	0.42	0.42	0.42	0.42	0.40	0.40	0.40	0.40	0.37	0.37	0.37	0.37	0.50	0.50	0.50	0.500
Debt/EBITDA	2.06	3.97	4.28	4.24	4.24	4.23	3.53	3.26	3.17	3.04	2.78	2.83	2.67	2.75	2.72	2.52	2.43	3.56	3.43	3.36	3.364
Net Debt/EBITDA	1.42	2.99	3.22	3.19	3.19	2.82	2.36	2.18	2.12	1.91	1.74	1.78	1.68	2.14	2.12	1.97	1.89	2.67	2.57	2.52	2.522
Interest Coverage	8.37	6.65	5.39	5.06	4.56	5.24	6.96	7.71	9.76	11.44	16.66	22.60	22.10	15.72	18.45	14.16	10.00	14.18	12.01	12.25	12.247
Equity Multiplier	2.16	2.49	2.49	2.49	2.49	2.48	2.48	2.48	2.48	2.37	2.37	2.37	2.37	2.29	2.29	2.29	2.29	2.99	2.99	2.99	2.986
Cash Ratio	snapshot only																				0.531
Debt Service Coverage	snapshot only																				17.848
Cash to Debt	snapshot only																				0.250
FCF to Debt	snapshot only																				0.209
Defensive Interval	snapshot only																				353.8 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.70	0.56	0.59	0.60	0.62	0.54	0.56	0.59	0.61	0.62	0.64	0.65	0.67	0.63	0.65	0.66	0.67	0.59	0.58	0.57	0.572
Inventory Turnover	1.94	1.49	1.54	1.58	1.59	1.52	1.52	1.60	1.68	1.98	2.06	2.09	2.11	2.07	2.12	2.14	2.13	1.78	1.70	1.67	1.673
Receivables Turnover	5.05	5.95	6.17	6.38	6.51	6.92	7.15	7.55	7.87	6.90	7.20	7.32	7.50	6.79	6.92	7.06	7.12	6.65	6.58	6.49	6.490
Payables Turnover	7.91	8.77	9.03	9.29	9.32	8.61	8.63	9.04	9.51	8.93	9.33	9.46	9.53	8.70	8.89	8.99	8.95	8.67	8.28	8.13	8.133
DSO	72	61	59	57	56	53	51	48	46	53	51	50	49	54	53	52	51	55	55	56	56.2 days
DIO	188	244	237	231	230	240	240	229	218	185	177	174	173	176	172	171	171	205	214	218	218.2 days
DPO	46	42	40	39	39	42	42	40	38	41	39	39	38	42	41	41	41	42	44	45	44.9 days
Cash Conversion Cycle	214	264	256	248	247	251	248	237	226	197	188	186	183	188	184	182	182	217	226	230	229.6 days
Fixed Asset Turnover	snapshot only																				4.675
Operating Cycle	snapshot only																				274.4 days
Cash Velocity	snapshot only																				4.329
Capital Intensity	snapshot only																				1.846

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	-11.5%	-11.9%	-4.5%	3.5%	7.8%	14.1%	13.6%	16.1%	18.5%	17.7%	18.8%	14.4%	12.5%	12.0%	9.5%	9.8%	8.1%	4.0%	0.9%	-2.5%	-2.45%
Net Income	35.6%	3.8%	-32.5%	-70.6%	-79.1%	-45.4%	5.0%	1.8%	3.2%	1.7%	1.0%	49.1%	32.2%	1.9%	-15.9%	-3.5%	2.8%	42.6%	42.2%	35.8%	35.84%
EPS	36.3%	4.7%	-32.1%	-70.8%	-79.1%	-46.0%	3.5%	1.7%	3.2%	1.7%	1.0%	49.5%	31.6%	1.5%	-16.2%	-3.2%	4.4%	48.2%	51.6%	46.0%	46.03%
FCF	45.9%	-34.4%	-56.3%	-54.9%	-72.2%	5.6%	68.8%	1.2%	2.9%	1.1%	1.0%	71.2%	6.5%	-24.4%	-54.1%	-77.1%	-29.7%	15.7%	1.3%	4.6%	4.63%
EBITDA	-10.3%	-24.1%	-21.3%	-15.9%	-14.4%	-5.9%	21.5%	30.4%	34.2%	36.5%	24.9%	13.1%	16.3%	16.3%	7.6%	18.2%	16.1%	17.3%	20.4%	13.7%	13.74%
Op. Income	35.3%	-13.2%	-38.1%	-67.1%	-70.5%	-10.0%	38.7%	1.9%	2.5%	93.2%	62.5%	26.6%	21.6%	5.7%	-15.6%	-0.1%	6.0%	22.5%	43.1%	38.4%	38.40%
OCF Growth	snapshot only																				2.40%
Asset Growth	snapshot only																				11.63%
Equity Growth	snapshot only																				-14.49%
Debt Growth	snapshot only																				51.62%
Shares Change	snapshot only																				-6.98%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	-0.5%	-1.2%	-0.7%	-0.2%	0.0%	0.9%	1.7%	3.1%	4.2%	5.7%	8.8%	11.1%	12.8%	14.6%	13.9%	13.4%	12.9%	11.1%	9.5%	7.0%	7.01%
Revenue 5Y	-0.2%	-0.9%	-0.0%	0.6%	1.1%	2.3%	3.0%	4.0%	4.7%	5.3%	5.7%	5.7%	5.9%	6.2%	6.4%	6.6%	6.6%	6.6%	7.3%	8.0%	8.03%
EPS 3Y	—	22.9%	42.9%	15.0%	-20.4%	-7.1%	10.6%	8.4%	6.6%	14.7%	12.6%	6.3%	5.3%	13.5%	20.7%	58.5%	80.1%	58.9%	37.1%	28.3%	28.35%
EPS 5Y	—	—	—	—	7.3%	—	75.0%	81.5%	—	21.8%	43.7%	44.2%	23.1%	16.8%	18.2%	13.0%	10.7%	17.8%	12.6%	11.2%	11.18%
Net Income 3Y	—	20.4%	41.8%	13.7%	-21.1%	-7.6%	11.1%	8.1%	6.3%	14.7%	12.7%	6.5%	5.4%	13.9%	21.2%	58.2%	79.2%	56.9%	34.1%	25.0%	25.03%
Net Income 5Y	—	—	—	—	7.0%	—	74.2%	80.5%	—	20.4%	43.3%	43.3%	22.4%	16.4%	18.4%	12.7%	10.3%	17.0%	11.3%	9.6%	9.64%
EBITDA 3Y	17.0%	8.5%	9.4%	8.5%	1.3%	-1.4%	0.2%	1.1%	1.0%	-0.8%	6.1%	7.5%	10.1%	14.3%	17.7%	20.3%	21.9%	23.0%	17.4%	15.0%	14.99%
EBITDA 5Y	12.1%	7.6%	7.8%	7.1%	6.8%	8.4%	7.3%	9.2%	13.0%	10.4%	14.7%	13.5%	10.2%	8.7%	6.2%	6.7%	6.8%	5.9%	9.1%	10.8%	10.77%
Gross Profit 3Y	3.6%	1.2%	3.5%	4.2%	5.5%	8.0%	7.4%	8.4%	8.3%	8.5%	11.9%	14.5%	16.7%	18.5%	17.4%	17.0%	16.3%	12.7%	11.1%	8.5%	8.52%
Gross Profit 5Y	0.4%	0.6%	2.1%	2.9%	4.1%	6.8%	8.0%	9.3%	9.5%	8.6%	9.9%	10.0%	10.8%	11.3%	10.0%	9.8%	9.5%	9.1%	10.6%	11.4%	11.44%
Op. Income 3Y	—	16.9%	21.0%	-1.1%	-18.3%	-1.1%	19.2%	14.3%	11.4%	14.7%	11.7%	6.8%	7.5%	22.5%	23.9%	54.8%	64.7%	35.7%	25.2%	20.5%	20.51%
Op. Income 5Y	—	—	—	—	4.4%	—	84.8%	96.0%	—	22.7%	31.9%	29.1%	18.1%	14.6%	18.4%	13.6%	12.3%	14.3%	11.0%	11.0%	11.01%
FCF 3Y	-2.3%	-21.0%	-23.5%	-13.0%	-23.1%	23.4%	31.0%	31.9%	16.7%	14.2%	13.8%	18.5%	5.1%	19.7%	15.7%	-5.5%	43.1%	23.4%	29.1%	30.1%	30.09%
FCF 5Y	32.9%	29.8%	4.1%	-2.5%	-18.2%	-2.0%	-2.6%	-1.2%	0.3%	2.3%	8.6%	19.5%	13.7%	25.0%	15.6%	-2.1%	3.5%	5.4%	9.7%	16.5%	16.45%
OCF 3Y	-8.0%	-21.0%	-22.5%	-18.6%	-18.6%	2.6%	15.9%	32.6%	25.5%	20.0%	14.3%	16.3%	8.7%	18.7%	12.4%	-8.1%	6.9%	1.8%	1.6%	3.7%	3.66%
OCF 5Y	4.4%	-2.2%	-7.8%	-6.7%	-9.9%	1.5%	5.2%	6.8%	5.8%	4.4%	4.1%	5.2%	0.1%	2.7%	-0.5%	-5.3%	-0.5%	2.8%	6.2%	11.6%	11.64%
Assets 3Y	0.8%	13.7%	13.7%	13.7%	13.7%	13.4%	13.4%	13.4%	13.4%	15.2%	15.2%	15.2%	15.2%	6.5%	6.5%	6.5%	6.5%	9.6%	9.6%	9.6%	9.64%
Assets 5Y	-3.1%	6.7%	6.7%	6.7%	6.7%	8.5%	8.5%	8.5%	8.5%	9.4%	9.4%	9.4%	9.4%	11.5%	11.5%	11.5%	11.5%	14.1%	14.1%	14.1%	14.10%
Equity 3Y	-7.4%	-0.9%	-0.9%	-0.9%	-0.9%	3.9%	3.9%	3.9%	3.9%	11.7%	11.7%	11.7%	11.7%	9.5%	9.5%	9.5%	9.5%	3.1%	3.1%	3.1%	3.08%
Book Value 3Y	-6.4%	1.2%	-0.2%	0.1%	0.0%	4.5%	3.5%	4.2%	4.2%	11.7%	11.6%	11.5%	11.6%	9.1%	9.0%	9.6%	10.0%	4.4%	5.4%	5.8%	5.81%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.09	0.01	0.04	0.03	0.04	0.15	0.38	0.43	0.42	0.48	0.58	0.63	0.63	0.64	0.69	0.75	0.79	0.86	0.92	0.93	0.928
Earnings Stability	0.88	0.88	0.82	0.58	0.27	0.43	0.63	0.41	0.34	0.39	0.65	0.43	0.25	0.48	0.53	0.33	0.26	0.63	0.59	0.53	0.532
Margin Stability	0.94	0.94	0.94	0.94	0.93	0.91	0.91	0.91	0.92	0.94	0.92	0.91	0.91	0.91	0.93	0.94	0.94	0.96	0.95	0.94	0.943
Rev. Growth Consistency	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.000
Earn. Growth Consistency	1.00	1.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	0.00	0.00	1.00	1.00	0.50	0.50	0.500
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.86	0.98	0.87	0.50	0.50	0.82	0.98	0.50	0.50	0.50	0.50	0.80	0.87	0.99	0.94	0.99	0.99	0.83	0.83	0.86	0.857
Earnings Smoothness	0.70	0.96	0.61	0.00	0.00	0.41	0.95	0.07	0.00	0.09	0.33	0.61	0.72	0.98	0.83	0.96	0.97	0.65	0.65	0.70	0.696
ROE Trend	0.09	0.00	-0.03	-0.10	-0.12	-0.06	-0.04	0.00	0.02	0.06	0.08	0.08	0.08	0.02	-0.01	-0.01	-0.01	0.07	0.06	0.06	0.062
Gross Margin Trend	0.03	0.03	0.02	0.02	0.02	0.04	0.05	0.05	0.04	0.02	0.01	0.01	0.02	0.01	0.00	0.01	0.01	0.01	0.03	0.03	0.030
FCF Margin Trend	0.05	0.01	-0.03	-0.03	-0.07	-0.02	-0.01	0.01	0.03	0.06	0.07	0.08	0.03	-0.01	-0.05	-0.10	-0.04	-0.01	0.04	0.10	0.096
Sustainable Growth Rate	17.2%	12.1%	9.8%	4.7%	3.4%	5.9%	9.1%	11.6%	12.9%	14.7%	17.4%	16.4%	16.2%	13.2%	12.9%	13.9%	14.6%	18.8%	18.3%	18.9%	18.89%
Internal Growth Rate	9.3%	5.4%	4.4%	2.1%	1.5%	2.4%	3.8%	4.9%	5.5%	6.5%	7.8%	7.3%	7.1%	6.0%	5.9%	6.4%	6.7%	7.8%	7.6%	7.8%	7.80%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.42	1.37	1.48	3.51	4.68	3.97	3.19	3.02	2.73	2.37	1.83	2.04	1.56	1.55	1.18	0.69	0.99	1.08	1.39	1.72	1.719
FCF/OCF	0.77	0.66	0.55	0.49	0.31	0.44	0.41	0.45	0.49	0.60	0.70	0.76	0.69	0.68	0.60	0.54	0.74	0.78	0.84	0.89	0.886
FCF/Net Income	snapshot only																				1.523
OCF/EBITDA	snapshot only																				0.794
CapEx/Revenue	4.1%	4.3%	4.8%	6.0%	7.7%	9.7%	12.5%	13.2%	11.8%	9.4%	6.1%	5.1%	4.8%	4.5%	4.1%	2.9%	2.4%	2.9%	2.8%	2.5%	2.48%
CapEx/Depreciation	snapshot only																				0.288
Accruals Ratio	-0.04	-0.02	-0.02	-0.05	-0.05	-0.07	-0.08	-0.09	-0.09	-0.08	-0.06	-0.07	-0.04	-0.03	-0.01	0.02	0.00	-0.01	-0.03	-0.05	-0.052
Sloan Accruals	snapshot only																				-0.097
Cash Flow Adequacy	snapshot only																				8.770
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	87.2%	78.3%	65.0%	54.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	89.5%	91.8%	1.3%	1.34%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.0%	1.9%	1.8%	1.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	4.8%	4.2%	9.8%	9.80%
Net Buyback Yield	0.0%	-0.2%	-0.3%	-0.3%	-0.3%	-0.1%	-0.2%	1.8%	1.7%	1.6%	1.5%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.2%	-17.7%	-15.6%	-21.0%	-21.02%
Total Shareholder Return	0.0%	-0.2%	-0.3%	-0.3%	-0.3%	-0.1%	-0.2%	1.8%	1.7%	1.6%	1.5%	-0.1%	-0.1%	-0.1%	-0.1%	-0.1%	-0.2%	-17.7%	-15.6%	-21.0%	-21.02%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.85	0.72	0.68	0.52	0.42	0.68	0.73	0.76	0.77	0.82	0.82	0.81	0.79	0.77	0.78	0.78	0.79	0.79	0.78	0.77	0.775
Interest Burden (EBT/EBIT)	1.04	0.99	1.00	0.65	0.60	0.71	0.74	0.77	0.80	0.84	0.88	0.86	0.80	0.74	0.73	0.72	0.73	0.93	0.87	0.87	0.869
EBIT Margin	0.14	0.13	0.10	0.10	0.09	0.09	0.12	0.14	0.14	0.14	0.16	0.15	0.16	0.16	0.15	0.16	0.16	0.17	0.18	0.19	0.188
Asset Turnover	0.70	0.56	0.59	0.60	0.62	0.54	0.56	0.59	0.61	0.62	0.64	0.65	0.67	0.63	0.65	0.66	0.67	0.59	0.58	0.57	0.572
Equity Multiplier	2.03	2.34	2.34	2.34	2.34	2.48	2.48	2.48	2.48	2.42	2.42	2.42	2.42	2.32	2.32	2.32	2.32	2.61	2.61	2.61	2.609

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$2.11	$1.56	$1.27	$0.61	$0.44	$0.84	$1.31	$1.67	$1.87	$2.25	$2.66	$2.50	$2.46	$2.29	$2.23	$2.42	$2.57	$3.39	$3.38	$3.53	$3.53
Book Value/Share	$11.43	$14.39	$14.36	$14.22	$14.25	$14.59	$14.50	$14.54	$14.63	$15.97	$15.93	$15.92	$15.90	$18.67	$18.62	$18.73	$18.96	$16.59	$16.98	$17.22	$17.23
Tangible Book/Share	$4.74	$-1.97	$-1.97	$-1.95	$-1.95	$-0.55	$-0.54	$-0.55	$-0.55	$1.48	$1.48	$1.48	$1.48	$-0.22	$-0.22	$-0.22	$-0.22	$-4.83	$-4.95	$-5.02	$-5.02
Revenue/Share	$17.21	$17.12	$17.74	$18.15	$18.57	$19.34	$19.85	$21.02	$22.05	$22.82	$23.73	$24.11	$24.69	$25.46	$25.87	$26.57	$27.12	$27.50	$27.84	$27.86	$28.86
FCF/Share	$2.29	$1.41	$1.02	$1.05	$0.64	$1.48	$1.70	$2.26	$2.50	$3.18	$3.42	$3.87	$2.65	$2.39	$1.56	$0.89	$1.89	$2.88	$3.91	$5.37	$5.63
OCF/Share	$2.99	$2.14	$1.87	$2.13	$2.06	$3.35	$4.18	$5.03	$5.11	$5.33	$4.87	$5.10	$3.83	$3.54	$2.62	$1.66	$2.55	$3.67	$4.69	$6.06	$6.34
Cash/Share	$2.67	$3.78	$3.78	$3.74	$3.75	$5.05	$5.02	$5.03	$5.07	$5.55	$5.54	$5.53	$5.53	$3.48	$3.47	$3.49	$3.53	$6.20	$6.34	$6.44	$5.31
EBITDA/Share	$4.18	$3.86	$3.57	$3.57	$3.58	$3.60	$4.27	$4.64	$4.81	$4.92	$5.37	$5.27	$5.57	$5.70	$5.76	$6.25	$6.57	$6.95	$7.39	$7.64	$7.64
Debt/Share	$8.60	$15.31	$15.28	$15.12	$15.16	$15.20	$15.11	$15.14	$15.24	$14.95	$14.92	$14.90	$14.89	$15.71	$15.67	$15.76	$15.95	$24.76	$25.33	$25.70	$25.70
Net Debt/Share	$5.93	$11.52	$11.50	$11.39	$11.41	$10.15	$10.09	$10.11	$10.18	$9.40	$9.38	$9.37	$9.36	$12.24	$12.20	$12.28	$12.42	$18.55	$18.99	$19.26	$19.26

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.099
Altman Z-Prime	snapshot only																				3.587
Piotroski F-Score	6	7	7	6	7	6	7	7	7	8	8	9	8	6	5	6	6	6	7	7	7
Beneish M-Score	-2.52	-2.57	-2.42	-2.54	-2.60	-2.76	-2.73	-2.74	-2.70	-2.68	-2.63	-2.70	-2.57	-2.43	-2.31	-2.20	-2.29	-2.48	-2.62	-2.68	-2.681
Ohlson O-Score	snapshot only																				-6.836
Net-Net WC	snapshot only																				$-14.58
EVA	snapshot only																				$5564700.34

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				BBB+
Credit Score	78.66	69.85	56.51	63.30	51.68	54.52	65.29	69.85	69.85	79.58	82.36	83.74	83.52	80.85	76.70	74.67	73.51	57.84	63.56	61.68	61.679
Credit Grade	snapshot only																				8
Credit Trend	snapshot only																				-12.995
Implied Spread (bps)	snapshot only																				225.000
Industry Credit Rank	snapshot only																				44
Sector Credit Rank	snapshot only																				62

HAE NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet